Series A funding round for Neumora Therapeutics raising $400M in October 2021
Series A funding round for Neumora Therapeutics raising $400M in October 2021
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Private | — | |
| Venture Capital | — | |
| Private | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$510M
Top Valuation
-
Neumora Therapeutics raised $400M in a Series A round.
The round was announced on 10/01/21.
The round was led by ARCH Venture Partners.